Rees: Startups can use high user volume instead of clinical studies for B2B sales
Amanda Rees · B2C2B in Digital Health, a founder's playbook · Dec 2, 2021 · at 20:30
Amanda Rees was not on this episode. A recording of them was played into it, so these are their words but not an appearance on the a16z Podcast. It still counts as said, and it is kept out of every score on their page.
Amanda Rees is the co-founder and CEO of Bold, a digital health startup. She discusses strategy for pitching enterprise buyers.
0:00 / 0:20exact quote · 20.4s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“So maybe you haven't done a research study, but you have really, really big volume, and you can start collecting that data, or you can start saying like, I just have already have this existing base of many, many individuals. I think that's another way to position and share impact when you're having B to B conversations.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →